|
Post by mindovermatter on Jan 14, 2016 12:36:48 GMT -5
The Danbury facility has got to be worth over $100 mln. It is used to securitize the Deefield loan of $74 mln? Is it possible to sell the plant to Deerfield, extinguish the debt, get cash out? This would open up money from the Mann group. MNKD would lease the buildings from Deerfield. That would be the last possible thing Mannkind would ever do. Why would they sell their crown jewel production facility?
|
|
|
Post by mindovermatter on Jan 14, 2016 11:53:36 GMT -5
Yesterday's conference gave some reassurance however I still have little confidence that anything significant will happen for MannKind in the near future. I'm sure I won't see $3.90 for years (if ever again; ugh) so the question remains...even if MannKind survives (a.k.a. barely stays afloat & treads water in the 0.75 range) will they actually thrive beyond 2016? Scary to know their innovative Technosphere technology may just fade away? I'm still in disbelief that this company cannot raise capital despite Afrezza's superior reports/results from Type 1 & Type 2 user feedback over the last year! Are people buying under $1 PPS and brave enough to think MannKind will rise from the ashes and help change modern medicine? Serious analysis and thoughts are appreciated... If sentiment changes to the positive for Mannkind, ie scripts move upwards based on change of strategy, revenue, new partnership, Wall Street upgrading, the PPS will move too. I am not saying any of this will happen any time soon, but a quick change of sentiment to the positive can surely move the stock up quickly.
|
|
|
Post by mindovermatter on Jan 14, 2016 11:49:38 GMT -5
I bought thousands of shares before the presentation. Got my pps to nearly $2/share even though it will go up a few cents after I an assigned a few thousand more shares upon options expiration this weekend (for a LOT more than $1/share). Don't think we are going away. With the sale of the Valencia property, settlement from SNY, and a few $$ coming in from Technosphere deals, I think we will have more than enough cash to keep in operation. With that time, everything else will fall into place. Clinics, overseas sales and yes, even American sales. We know it works. Even without a cgm and a lazy tester to boot, we got it dialed in. Once the word gets out there, I can't imagine ONE diabetic that needs to transition to insulin say: " yeah, I'd prefer to stick myself eight times a day". And when Afrezza is approved for children??? Watch the market jump into the stratosphere. I can't imagine any parent on the planet who wants to inflict pain in their child many many times a day. At some time in the future, diabetic children may be able to act exactly like their peers. When another student brings in cupcakes for his birthday, six year old little Jenny just whips her whistle from her pocket and inhales... And eats the cupcake. You don't need to be a rocket scientist to see this equation. And, with the plan to raise additional capital, even without dilution, we have enough now to make all these things happen. (Note: Be cognizant, we will be dilutingin the future, albeit at higher share prices). As I keep telling my husband, in a few years, when we are ready to retire, we are going to be very, very happy that we invested in this company. Think about ask those people who invested in Apple during its darkest days. They are now rolling around in an "embarrassment of riches". The Valencia property has been on the market for awhile now. There is no knowing when it will sell. Matt said they have received many low ball offers but refused those. I wouldn't count on it selling anytime soon, at least at what they want for it imo.
|
|
|
Post by mindovermatter on Jan 14, 2016 11:20:52 GMT -5
important to mention that Matt stated the Pediatric study's costs are negligible or something to that extent. As such, he's not worried about Mannkind taking it over. I actually think Afrezza's will be more valuable to this segment than any other. What endo or PCP is going to actually take injections over inhaling?
|
|
|
Post by mindovermatter on Jan 14, 2016 10:54:19 GMT -5
Based on Matt's presentation I think it is safe to assume a TS deal will be announced within the next 30 days. Hopefully, if announced, this will get the MNKD train rolling again. It all depends on the deal and how Mannkind is favored. The Sanofi deal helped the stock for one day and then it started to deflate as Wall Street didn't think it was in Mannkind's favor. And obviously up front money and a lot of it would be welcomed.
|
|
|
Post by mindovermatter on Jan 14, 2016 10:32:04 GMT -5
I was wondering about whether we have any movement forward in getting CGMs widely covered by insurance, Medicare and Medicaid. Matt's observation that this was a big distinction between those who persevered and those who didn't was important bc patients can "see" Afrezza work. In the absence of a new expensive trial for a better label, I think this CGM coverage is very important for Afrezzas success. Anyone know? Mannkind has nothing to do with CGM coverage. Those companies that make CGMs have been at it for a long time with insurance companies and I am sure they are trying all they can to make their CGMs as available as possible. The other issue is whether or not many diabetics want them. Remember, it's just another thing to have to to pay attention to and we already know that many diabetics are not that great in taking care of their disease.
|
|
|
Post by mindovermatter on Jan 14, 2016 9:51:03 GMT -5
So my good fortune relies upon a gutty lil Bruin.....Ughhhhhhh Took a few finance courses there in the 80's! Should have paid closer attention now that i think about it Also, it would seem a concurrent major DTC campaign would be needed to drive traffic to these clinics. Lots more money needed Here's a thought. ADA wouldn't support Afrezza specific clinics. But would it support Diabetic Education training centers that just happen to show case Afrezza as one of various remedies? I think they would. Think about that.
|
|
|
Post by mindovermatter on Jan 13, 2016 23:18:40 GMT -5
|
|
|
Post by mindovermatter on Jan 13, 2016 19:45:56 GMT -5
Those "clinics" are the product of marketing acumen, creativity and hard work. Hope they work out as well as they should. They can tell it like it is to their potential patients. I would think they have the endos they need in key areas to start this pilot program. If successful, then send those endos or RNs/educators out to other parts to train others would be my guess.
|
|
|
Post by mindovermatter on Jan 13, 2016 19:13:48 GMT -5
Cash is a major concern. Hopefully something happens soon in the way of a partnership. My sense is that they are going to keep US distribution and create multiple partnerships for ROW as a way to create cash while they do smaller partnerships for T/S applications to perform the clinical studies. Matt said what I have mentioned before. SNY could possibly give MNKD a nice cash good bye present. It's being negotiated. Whether or not they'll get anything remains to be seen but Matt hinted it's being discussed.
|
|
|
Post by mindovermatter on Jan 13, 2016 13:54:48 GMT -5
They will report that they are looking into new cash infusion (they bought a powerball ticket and are hopeful). BTW, if I win powerball, I plan to buy mnkd, and slash the price of afrezza in half, I cannot think of a better way to help so many people in need. I will keep Matt on though, as I will still need a CEO, CFO, secretary, security guard and janitor. if you were lucky enough to win the Powerball, the most idiotic thing you could do is to dump any money into Mannkind. The ship is sinking and no one knows if Matt can plug the holes fast enough before it takes on too much water.
|
|
|
Post by mindovermatter on Jan 12, 2016 22:36:05 GMT -5
Is it possible that Takeda market Afrezza in Asia, Novo in USA etc.... Different partners for different countries? possible but not probable.
|
|
|
Post by mindovermatter on Jan 12, 2016 22:15:38 GMT -5
I got a firm confirmation that Mnkd wouldn't pull out of the Conf, Ray (CMO) will present TS Road Map. Matt will present Afrezza game plan, strategic options including future partners, marketing strategy, financial situation, business model, plan to extend runway. There are 2 presenters from Mnkd, suprised !!Also heard TS partner for Pain mgmt, Migraine....... Individual investors can post questions and get immediate answers. It gonna be an open forum, no holds barred, only time is the limiting factor. Please come prepare with written, electronic Qs so that you can cut and paste fast. Let's seize this opportunity to really grill mgmt. Don't complain if you are not prepared. said Kent Kresa, Lead Director of MannKind Corporation. "He understands the strategic and financial challenges that we face at this very important time for our company and has already begun to pursue a number of solutions." Lakers I hope your right on this one - We'll know really soon. If he is right wouldn't it be the first time he was actually right about something?
|
|
|
Post by mindovermatter on Jan 12, 2016 16:13:09 GMT -5
Individual links are posted on MNKD's website for the presentation and Q&A segments at JPM. The link below will take you to the page on the website where you can get the links for each. investors.mannkindcorp.com/events.cfmI'll be there with my pitchfork, bucket of tar and bag of feathers. I'll see if I can get a selfie with Matt.
|
|
|
Post by mindovermatter on Jan 12, 2016 15:43:01 GMT -5
If anyone is wondering where I went on StockTwits, I've been suspended for spamming multiple tickers. Although the last few messages have contained multiple tickers, I believe that the info I was providing pertained to those tickers. Obviously StockTwits didn't think so. I have requested that my account be un-suspended but still waiting to hear from them. If you are on ST and want to support me, please email them asking to reinstate my account. Maybe they suspended you because you aren't a big enough of a twit? Seriously though, is it that important that you have to post it here? It's a message board for god's sake. As Don Corleone said, "YOU CAN ACT LIKE A MAN! What's the matter with you? Is this what you've become, a Hollywood finocchio who cries like a woman? "Oh, what do I do? What do I do?" What is that nonsense? Ridiculous!"
|
|